Showing 1-5 of 37 resources:
Achieving a Win-Win for Pharma and Payers in Contracting Agreements

Published on PM360, April 2, 2018 The shift to value-based care and outcomes contracting type programs present the opportunity to align stakeholder interests around value and demonstrate a commitment to improving clinical and cost outcomes. From earlier detection to more precision management, the opportunities for pharma to partner around outcomes and value are growing. Win-wins[…]

New AHRQ E-Book on Patient Registry Issues Developed Under OM1 Contract

BOSTON, March 19, 2018 — The U.S. Agency for Healthcare Research and Quality (AHRQ) today announced the release of a series of publications on the evolving role of patient registries, including increasing the patient focus. Under contract to AHRQ and L&M Policy Research, OM1, a leading health outcomes and registries company focused on the measurement,[…]

Using Big Data Like Biomarkers to Advance Clinical Development & Commercialization

March 28, 2018 – 2 PM ET What if you could use predictive models like biomarkers to pre-emptively screen and more effectively target patients who are more likely to respond to your drug in trials and in practice? What if you could rapidly answer questions on comparative treatment outcomes and predict those most likely to[…]

Feb 28 – Outcomes as a Pathway for Payer-Pharma-Provider Collaboration

February 28, 2018 – 2:00 pm – 3:00 pm ET Join Dr. Richard Gliklich, CEO of OM1, to explore the opportunities with using big data, predictive analytics and measurable outcomes to develop and implement outcomes based programs that align stakeholder incentives around benefits and costs.  Discussion will include: Using standardized outcomes measurement Predicting treatment benefit,[…]

1 2 3 8